Nkarta, Inc.

NasdaqGS:NKTX Stock Report

Market Cap: US$230.7m

Nkarta Management

Management criteria checks 3/4

Nkarta's CEO is Paul Hastings, appointed in Feb 2018, has a tenure of 6.75 years. total yearly compensation is $2.93M, comprised of 21.2% salary and 78.8% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $250.69K. The average tenure of the management team and the board of directors is 4.1 years and 4.8 years respectively.

Key information

Paul Hastings

Chief executive officer

US$2.9m

Total compensation

CEO salary percentage21.2%
CEO tenure6.8yrs
CEO ownership0.1%
Management average tenure4.1yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Nkarta: Catalysts Ahead, But Competition In Cell Therapy Too (Rating Downgrade)

Oct 31

We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely

Sep 10
We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely

Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients

Aug 14

Nkarta: A Look Into Q1 Results And Upcoming Catalysts

May 23

Nkarta: Down 50% Since March With A Clinical Catalyst Ahead

Apr 27

Nkarta: NK Cell Therapy Advancement On Two Fronts

Mar 25

Nkarta: Possible Upside From H1 Update, If Positive

Jan 25

Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Jan 16
Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation

We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Oct 04
We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate

We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Jun 21
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Mar 06
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Nov 20
Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Nkarta GAAP EPS of -$0.61

Aug 11

We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Jun 09
We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Nkarta: A Promising Natural Killer Cell Play

May 20

We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Aug 23
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans

May 10
Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans

Nkarta gets greenlight from the FDA for NKX019 cancer study

Apr 28

We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Jan 25
We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

CEO Compensation Analysis

How has Paul Hastings's remuneration changed compared to Nkarta's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$111m

Jun 30 2024n/an/a

-US$108m

Mar 31 2024n/an/a

-US$116m

Dec 31 2023US$3mUS$624k

-US$118m

Sep 30 2023n/an/a

-US$122m

Jun 30 2023n/an/a

-US$125m

Mar 31 2023n/an/a

-US$119m

Dec 31 2022US$5mUS$600k

-US$114m

Sep 30 2022n/an/a

-US$104m

Jun 30 2022n/an/a

-US$98m

Mar 31 2022n/an/a

-US$93m

Dec 31 2021US$7mUS$576k

-US$86m

Sep 30 2021n/an/a

-US$81m

Jun 30 2021n/an/a

-US$72m

Mar 31 2021n/an/a

-US$102m

Dec 31 2020US$3mUS$560k

-US$91m

Sep 30 2020n/an/a

-US$84m

Jun 30 2020n/an/a

-US$73m

Mar 31 2020n/an/a

-US$27m

Dec 31 2019US$3mUS$543k

-US$21m

Compensation vs Market: Paul's total compensation ($USD2.93M) is above average for companies of similar size in the US market ($USD1.47M).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.

CEO

Paul Hastings (64 yo)

6.8yrs

Tenure

US$2,934,715

Compensation

Mr. Paul J. Hastings had been President of Nkarta, Inc. since February 2018 until July 2024 and serves as its Chief Executive Officer as well as Director since February 2018. He is Independent Director of...

Leadership Team

NamePositionTenureCompensationOwnership
Paul Hastings
CEO & Director6.8yrsUS$2.93m0.11%
$ 250.7k
Alyssa Levin
Chief Financial & Business Officer and Principal Accounting Officer1.3yrsUS$1.51m0%
$ 0
David Shook
Chief Medical Officer & Head of Research and Development1.8yrsUS$1.51m0.029%
$ 66.1k
Nadir Mahmood
Presidentless than a yearUS$1.82m0.044%
$ 102.6k
Ralph Brandenberger
Chief Technical Officer4.8yrsno data0.0058%
$ 13.4k
Greg Mann
Vice President of Public Affairs and Investor Relations4.8yrsno datano data
Alicia Hager
Chief Legal Officer & Corporate Secretary4.1yrsUS$2.06m0.013%
$ 30.4k

4.1yrs

Average Tenure

50yo

Average Age

Experienced Management: NKTX's management team is considered experienced (4.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Paul Hastings
CEO & Director6.8yrsUS$2.93m0.11%
$ 250.7k
Ali Behbahani
Independent Chairman9.1yrsUS$166.75k0%
$ 0
Leone Patterson
Independent Director4.6yrsUS$136.25k0%
$ 0
Lewis Lanier
Member of Scientific Advisory Boardno datano datano data
Michael Dybbs
Independent Director5.3yrsUS$135.25k0%
$ 0
Simeon George
Independent Director4.8yrsUS$126.25k0%
$ 0
Dario Campana
Member of Scientific Advisory Boardno datano datano data
Zachary Scheiner
Independent Director4.8yrsUS$125.25k0%
$ 0
Angela Thedinga
Independent Director2.7yrsUS$122.50k0%
$ 0
George Vratsanos
Directorless than a yearno datano data

4.8yrs

Average Tenure

48yo

Average Age

Experienced Board: NKTX's board of directors are considered experienced (4.8 years average tenure).